Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

  1. Dalbeth, N.
  2. Jones, G.
  3. Terkeltaub, R.
  4. Khanna, D.
  5. Kopicko, J.
  6. Bhakta, N.
  7. Adler, S.
  8. Fung, M.
  9. Storgard, C.
  10. Baumgartner, S.
  11. Perez-Ruiz, F.
Journal:
Arthritis and Rheumatology

ISSN: 2326-5205 2326-5191

Year of publication: 2017

Volume: 69

Issue: 9

Pages: 1903-1913

Type: Article

DOI: 10.1002/ART.40159 GOOGLE SCHOLAR lock_openOpen access editor